tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

TOVX Stock Latest News

Theriva Licenses SYN-020, Refocuses on Cancer Pipeline
Company AnnouncementsTheriva Licenses SYN-020, Refocuses on Cancer Pipeline
9d ago
8K
TOVX
Theriva Biologics licenses SYN-020 to Rasayana Therapeutics
PremiumThe Fly
Theriva Biologics licenses SYN-020 to Rasayana Therapeutics
9d ago
TOVX
Theriva Biologics Faces Delay in Warrant Approval Meeting
PremiumCompany Announcements
Theriva Biologics Faces Delay in Warrant Approval Meeting
15d ago
8K
TOVX
Theriva Biologics advances VCN-01 toward Phase 3 trial
PremiumCompany Announcements
Theriva Biologics advances VCN-01 toward Phase 3 trial
2M ago
8K
TOVX
Theriva Biologics Gains EMA Backing for VCN-01 Phase 3
PremiumCompany Announcements
Theriva Biologics Gains EMA Backing for VCN-01 Phase 3
2M ago
8K
TOVX
Theriva Biologics receives CHMP scientific advice on VCN-01 Phase 3 design
PremiumThe FlyTheriva Biologics receives CHMP scientific advice on VCN-01 Phase 3 design
2M ago
TOVX
Theriva Biologics Reschedules Special Stockholder Meeting
Premium
Company Announcements
Theriva Biologics Reschedules Special Stockholder Meeting
2M ago
8K
TOVX
Theriva Biologics Advances Oncology Pipeline with VCN-01
Premium
Company Announcements
Theriva Biologics Advances Oncology Pipeline with VCN-01
4M ago
TOVX
Theriva Biologics reports Q3 EPS (45c) vs ($6.81) last year
PremiumThe Fly
Theriva Biologics reports Q3 EPS (45c) vs ($6.81) last year
4M ago
TOVX
Theriva Biologics files to sell 16.18M shares of common stock for holders
PremiumThe Fly
Theriva Biologics files to sell 16.18M shares of common stock for holders
4M ago
TOVX
Theriva Biologics sees no material development to account for unusual trading
PremiumThe Fly
Theriva Biologics sees no material development to account for unusual trading
4M ago
TOVX
Theriva Biologics Presents Promising Phase 2b Trial Data
PremiumCompany Announcements
Theriva Biologics Presents Promising Phase 2b Trial Data
4M ago
8K
TOVX
Theriva Biologics Secures $4M Through Warrant Agreement
PremiumCompany AnnouncementsTheriva Biologics Secures $4M Through Warrant Agreement
4M ago
8K
TOVX
Theriva Biologics announces warrant inducement transaction for $4M in proceeds
Premium
The Fly
Theriva Biologics announces warrant inducement transaction for $4M in proceeds
4M ago
TOVX
Theriva Biologics Presents Promising Phase 2b Trial Data
Premium
Company Announcements
Theriva Biologics Presents Promising Phase 2b Trial Data
5M ago
8K
TOVX
Theriva Biologics Presents Promising VCN-12 Preclinical Data
PremiumCompany Announcements
Theriva Biologics Presents Promising VCN-12 Preclinical Data
5M ago
8K
TOVX
Theriva Biologics Unveils VCN-12 Preclinical Data
PremiumCompany Announcements
Theriva Biologics Unveils VCN-12 Preclinical Data
5M ago
8K
TOVX
Theriva Biologics Restructures, Cuts Workforce by 32%
PremiumCompany Announcements
Theriva Biologics Restructures, Cuts Workforce by 32%
5M ago
8K
TOVX
Theriva Biologics Approves Key Proposals at Annual Meeting
PremiumCompany Announcements
Theriva Biologics Approves Key Proposals at Annual Meeting
6M ago
8K
TOVX
Theriva Biologics Faces Financial Risks Amid Shifting Trade Policies and Tariffs
PremiumCompany AnnouncementsTheriva Biologics Faces Financial Risks Amid Shifting Trade Policies and Tariffs
7M ago
TOVX
Theriva Biologics Reports Promising Trial Results and Financials
Premium
Company Announcements
Theriva Biologics Reports Promising Trial Results and Financials
7M ago
TOVX
Theriva Biologics reports Q2 EPS ($1.93) vs. ($10.72) last year
Premium
The Fly
Theriva Biologics reports Q2 EPS ($1.93) vs. ($10.72) last year
7M ago
TOVX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >